CADIAN CAPITAL MANAGEMENT, LP - KERYX BIOPHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 160 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
CADIAN CAPITAL MANAGEMENT, LP ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$3,030,000
+43.5%
600,0000.0%0.11%
+43.4%
Q3 2015$2,112,000
-64.7%
600,0000.0%0.08%
-56.8%
Q2 2015$5,988,000
-21.6%
600,0000.0%0.18%
-14.6%
Q1 2015$7,638,000–600,000–0.21%–
 Download
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders